美国处方药定价的新改革：机遇与挑战。 - Suppr

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

作者信息

Hwang Thomas J, Kesselheim Aaron S, Rome Benjamin N

机构信息

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

DOI:10.1001/jama.2022.15268

PMID:35984652

Abstract

摘要

相似文献

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

Value-Based Pricing and State Reform of Prescription Drug Costs.

JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.

Fair global drug pricing.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31.

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.

Physician and Patient Adjustment to Reference Pricing for Drugs.

JAMA Netw Open. 2020 Feb 5;3(2):e1920544. doi: 10.1001/jamanetworkopen.2019.20544.

Prescription Drug Pricing.

Ann Emerg Med. 2018 Oct;72(4):e59. doi: 10.1016/j.annemergmed.2018.07.029.

Payment Reforms, Prescription Drugs, And More.

Health Aff (Millwood). 2016 Sep 1;35(9):1555. doi: 10.1377/hlthaff.2016.1046.

Trends in Prescription Drug Spending Leading Up to Health Reform.

Med Care Res Rev. 2014 Aug;71(4):416-32. doi: 10.1177/1077558714533820. Epub 2014 May 14.

The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.

BMC Health Serv Res. 2020 Nov 23;20(1):1058. doi: 10.1186/s12913-020-05849-4.

引用本文的文献

Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review.

Eur J Health Econ. 2025 Sep 6. doi: 10.1007/s10198-025-01834-y.

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.

JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.

A Global Comparison of Liver Transplant Drug Pricing: US Versus Other G7 Countries and Australia.

Transplant Direct. 2025 May 12;11(6):e1805. doi: 10.1097/TXD.0000000000001805. eCollection 2025 Jun.

Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.

Health Aff Sch. 2025 Mar 21;3(3):qxaf030. doi: 10.1093/haschl/qxaf030. eCollection 2025 Mar.

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling.

Front Pharmacol. 2025 Jan 22;16:1474856. doi: 10.3389/fphar.2025.1474856. eCollection 2025.

Association of Medicare eligibility with access to and affordability of care among older cancer survivors.

J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01562-x.

Is the price right? Paying for value today to get more value tomorrow.

BMC Med. 2024 Jan 30;22(1):45. doi: 10.1186/s12916-024-03262-w.

Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.

J Manag Care Spec Pharm. 2024 Mar 1;30(3):269-278. doi: 10.18553/jmcp.2023.23153. Epub 2023 Dec 23.

Stakeholder Perspectives of the Inflation Reduction Act's (2022) Impact on Prescription Drugs: A Narrative Review.

Pharmacy (Basel). 2023 Dec 17;11(6):187. doi: 10.3390/pharmacy11060187.

Access in all areas? A round up of developments in market access and health technology assessment: part 2.

J Comp Eff Res. 2023 Dec;12(12):e230162. doi: 10.57264/cer-2023-0162. Epub 2023 Nov 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

作者信息

Hwang Thomas J, Kesselheim Aaron S, Rome Benjamin N

机构信息

Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

DOI:10.1001/jama.2022.15268

PMID:35984652

Abstract

摘要

相似文献

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

Value-Based Pricing and State Reform of Prescription Drug Costs.

JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.

Fair global drug pricing.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31.

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.

Physician and Patient Adjustment to Reference Pricing for Drugs.

JAMA Netw Open. 2020 Feb 5;3(2):e1920544. doi: 10.1001/jamanetworkopen.2019.20544.

Prescription Drug Pricing.

Ann Emerg Med. 2018 Oct;72(4):e59. doi: 10.1016/j.annemergmed.2018.07.029.

Payment Reforms, Prescription Drugs, And More.

Health Aff (Millwood). 2016 Sep 1;35(9):1555. doi: 10.1377/hlthaff.2016.1046.

Trends in Prescription Drug Spending Leading Up to Health Reform.

Med Care Res Rev. 2014 Aug;71(4):416-32. doi: 10.1177/1077558714533820. Epub 2014 May 14.

The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.

BMC Health Serv Res. 2020 Nov 23;20(1):1058. doi: 10.1186/s12913-020-05849-4.

引用本文的文献

Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review.

Eur J Health Econ. 2025 Sep 6. doi: 10.1007/s10198-025-01834-y.

Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.

JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.

A Global Comparison of Liver Transplant Drug Pricing: US Versus Other G7 Countries and Australia.

Transplant Direct. 2025 May 12;11(6):e1805. doi: 10.1097/TXD.0000000000001805. eCollection 2025 Jun.

Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.

Health Aff Sch. 2025 Mar 21;3(3):qxaf030. doi: 10.1093/haschl/qxaf030. eCollection 2025 Mar.

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling.

Front Pharmacol. 2025 Jan 22;16:1474856. doi: 10.3389/fphar.2025.1474856. eCollection 2025.

Association of Medicare eligibility with access to and affordability of care among older cancer survivors.

J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01562-x.

Is the price right? Paying for value today to get more value tomorrow.

BMC Med. 2024 Jan 30;22(1):45. doi: 10.1186/s12916-024-03262-w.

Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.

J Manag Care Spec Pharm. 2024 Mar 1;30(3):269-278. doi: 10.18553/jmcp.2023.23153. Epub 2023 Dec 23.

Stakeholder Perspectives of the Inflation Reduction Act's (2022) Impact on Prescription Drugs: A Narrative Review.

Pharmacy (Basel). 2023 Dec 17;11(6):187. doi: 10.3390/pharmacy11060187.

Access in all areas? A round up of developments in market access and health technology assessment: part 2.

J Comp Eff Res. 2023 Dec;12(12):e230162. doi: 10.57264/cer-2023-0162. Epub 2023 Nov 2.

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

作者信息

机构信息

出版信息

相似文献

引用本文的文献